Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Plasma Arginine Levels in Arginase Deficiency in the “Real World”

Plasma Arginine Levels in Arginase Deficiency in the “Real World”

Authors: Tanpaiboon P, Huang Y, Louie JZ, Sharma R, Cederbaum S, Salazar D

Citation: Mol Genet Metab Rep. 2023 Dec 28;38:101042. doi: 10.1016/j.ymgmr.2023.101042

Specialties: Genetics, Cardiology, Cardiovascular disease, Endocrinology

Related content

Publication
Combined arginine and insulin stimulation elicits a robust and consistent copeptin response in short children
Publication
Arginine to Ornithine Ratio as a Diagnostic Marker in Patients With Positive Newborn Screening for Hyperargininemia
Conference Presentation
The Arginine Stimulation Test Allows Rapid Diagnosis of Central Diabetes Insipidus in Children
Conference Presentation
Stimulated Copeptin Response to Arginine Insulin Tolerance Test A Novel Method to Assess Posterior Pituitary Function

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.